ABC News’ Genevieve Shaw Brown takes a tour of the only overnight room in the Magic Kingdom.
Left ventricular assist devices are usually only available as a last resort for patients with congestive heart failure, but a new study will examine the benefits of using heart devices before patients reach late-stage heart failure.
Physicians, researchers, patients and their advocates in the spinal injury field are keeping a close eye on Rockville biotech Neuralstem as it prepares to launch a Phase 1 safety trial of its stem cell treatment for chronic spinal cord injury.
Neuralstem Obtains FDA Approval To Commence Spinal Cord Injury Trial
Prosecutor paints Bay City’s Stephen Ashley as cold-blooded killer; defense says he’s a fearful young man, other top stories from Sunday, Jan. 13.
CHARLESTON, W.Va. — On the entertainment scene in downtown Charleston, hes what they call a player, an icon of sorts. At 43, New York transplant Paul Greco, known mostly as “PG,” owns two of the hottest spots in town — Sams Uptown Cafe and …
While safe and well-tolerated, angiotensin II blockade did not lessen tissue scarring or prevent kidney failure in kidney transplant recipients. Angiotensin II blockade is known to slow kidney disease progression in individuals without transplants.
The decision to fly the victim of a gang rape that outraged India for treatment in Singapore made little medical sense as the woman was so severely injured that her death was all but inevitable, doctors say.
NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver …
Research and Markets has announced the addition of the “Biogen-Idec’s and Facet Biotech’s Daclizumab: Can It Com